openPR Logo
Press release

Gastric Cancer Treatment Market Driven by Surge in FDA Approvals and R&D Investment

05-10-2025 02:33 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Gastric Cancer Treatment Market

Gastric Cancer Treatment Market

Gastric Cancer Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Gastric Cancer Treatment Market size reached US$ 5.82 billion in 2024 and is expected to reach US$ 14.66 billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/gastric-cancer-treatment-market?rk

Advancements in Targeted Therapies Propel Growth in the Gastric Cancer Treatment Market

The gastric cancer treatment market is witnessing robust growth, primarily driven by rapid advancements in targeted therapies. One of the most impactful developments has been the emergence of HER2-targeted treatments. HER2 (human epidermal growth factor receptor 2) is overexpressed in a subset of gastric cancer cases, promoting aggressive tumor growth. Trastuzumab (Herceptin), a monoclonal antibody targeting HER2, has revolutionized treatment protocols for HER2-positive gastric cancer when used alongside chemotherapy.

Further underscoring this trend, in October 2024, Astellas Pharma Inc. received FDA approval for VYLOY (zolbetuximab-clzb). This therapy, in combination with fluoropyrimidine- and platinum-based chemotherapy, is indicated as a first-line treatment for adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma that tests positive for claudin (CLDN) 18.2. Notably, VYLOY is the first and only CLDN18.2-targeted therapy approved in the U.S.

Gastric Cancer Treatment Market Recent Development:

In December 2024, BeiGene, Ltd.-a global oncology company planning to rebrand as BeOne Medicines Ltd.-announced that the U.S. Food and Drug Administration (FDA) approved TEVIMBRA (tislelizumab-jsgr). The approval covers its use in combination with platinum- and fluoropyrimidine-based chemotherapy as a first-line treatment for adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma whose tumors express PD-L1 (≥1).

List of the Key Players in the Gastric Cancer Treatment Market:

Merck & Co., Inc., Eli Lilly and Company, Genentech USA, Inc., Pfizer Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Blueprint Medicines Corporation, Daiichi Sankyo, Inc., BeiGene, Ltd., Ipsen Biopharmaceuticals Inc., Taiho Oncology, Inc., and Deciphera Pharmaceuticals, LLC., and among others.

Assessing the Effects of U.S. Tariffs on the Gastric Cancer Treatment Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Gastric Cancer Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/gastric-cancer-treatment-market?rk

Segment Covered in the Gastric Cancer Treatment Market:

By Cancer Type: Non-Cardia (Distal) Stomach Cancer, Proximal Stomach Cancer, Diffuse Stomach Cancer, Lymphomas, Gastrointestinal Stromal Tumors, Carcinoid Tumors, Adenocarcinoma, Others.

By Treatment Type: Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Surgery, Others.

By Route of Administration: Injectable, Oral.

Regional Analysis for Gastric Cancer Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Gastric Cancer Treatment Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Gastric Cancer Treatment market?

➠ Who are the top manufacturers in the global Gastric Cancer Treatment industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Gastric Cancer Treatment market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Gastric Cancer Treatment market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Gastric Cancer Treatment industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/gastric-cancer-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Cancer Treatment Market Driven by Surge in FDA Approvals and R&D Investment here

News-ID: 4009028 • Views:

More Releases from DataM Intelligence 4market Research LLP

Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic Therapies and Combination Treatments | Key Japanese Pharmaceutical Players Invest in Next-Gen CAR-T Cell Technologies
Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic T …
The Japan CAR-T cell therapies market reached US$ 346.00 million in 2024 and is expected to reach US$ 1,350.15 million by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033. The CAR-T Cell Therapies Market in Japan involves genetically engineered T-cells targeting cancer-specific antigens. Growth is driven by rising cancer incidence, advanced immunotherapies, and government support. Hospitals and specialized oncology centers are key end-users. Clinical trials focus on
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion by 2032 | Driving Innovations in Hypersonics and Green Propellants
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion …
Global Advanced Rocket and Missile Propulsion Systems Market size reached US$ 38.79 billion in 2024 and is expected to reach US$ 77.58 billion by 2032, growing with a CAGR of 9.05% during the forecast period 2025-2032. Advanced Rocket and Missile Propulsion Systems include solid, liquid, and hybrid engines used in defense, space, and aerospace applications. Growth is driven by defense modernization, space exploration, and missile defense initiatives. Technologies focus on high
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at a CAGR of 7.87% | Increasing Demand for Organic, Non-GMO, and Allergen-Free Labels
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at …
Global transparent food labeling market size reached US$ 43.21 billion in 2024 and is expected to reach US$ 79.21 billion by 2032, growing with a CAGR of 7.87% during the forecast period 2025-2032. Transparent Food Labeling involves providing clear, accurate information about ingredients, nutritional content, and allergens on packaged foods. Growth is driven by rising consumer awareness, health consciousness, and regulatory requirements. Labels often highlight organic, non-GMO, or allergen-free claims.
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI-Powered Compliance Tools | AI-Driven Analytics and Blockchain Enhance Efficiency in RegTech Compliance and Reporting
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI- …
Global RegTech Market reached US$ 20.04 billion in 2024 and is expected to reach US$ 33.36 billion by 2032, growing with a CAGR of 6.75% during the forecast period 2025-2032. The Regulatory Technology (RegTech) Market provides software and tools to ensure compliance, risk management, and reporting for financial institutions. Growth is driven by increasing regulations, fintech adoption, and fraud prevention needs. Solutions include AI-driven analytics, blockchain, and automated reporting systems.

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For